Pilonidal Excision Versus Endoscopic Surgery
Launched by ST HELENS & KNOWSLEY TEACHING HOSPITALS NHS TRUST · Apr 17, 2019
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
Primary outcome: complication rate Secondary outcomes: Quality of life, recurrence rate, length of stay, post operative pain (NRS), return to work time, time to complete wound healing, resource use.
Allocation ratio 2:1
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I or II
- • Pilonidal disease \<3 previous treatments
- • Previous incision and drainage allowed
- • Over 16 years
- Exclusion Criteria:
- • Co-morbidity \>ASA II
- • Unable to consent themselves
- • Under 16 years
- • Vulnerable adults
About St Helens & Knowsley Teaching Hospitals Nhs Trust
St Helens & Knowsley Teaching Hospitals NHS Trust is a leading healthcare organization dedicated to providing high-quality patient care through innovative clinical practices and research. As a prominent sponsor of clinical trials, the Trust is committed to advancing medical knowledge and improving treatment outcomes across a range of specialties. By fostering collaboration between healthcare professionals, researchers, and patients, the Trust aims to contribute to the development of evidence-based therapies and enhance the overall healthcare landscape. With a focus on patient safety and ethical research practices, St Helens & Knowsley Teaching Hospitals NHS Trust plays a vital role in translating clinical research into meaningful health improvements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Prescot, Merseyside, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials